Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Vassar

Showing results (11-20 of 418) with videos related to

Pageof 42
Sort By:
Journal of Dermatological Science|June 18, 2016
Cumulative meta-analysis by precision as a method to evaluate publication biasPaul Atakpo, Matt Vassar
Clinical Obesity|September 6, 2017
Response to: stated conclusion about industry funding is opposite to what the paper's data show: letter regarding "Selective outcome reporting in obesity clinical trials: a cross-sectional review"Andrew Ross, Matt Vassar
Journal of Educational Evaluation for Health Professions|June 4, 2011
An overview of ethnography in healthcare and medical education researchLeigh Goodson, Matt Vassar
BMJ (Clinical Research Ed.)|May 29, 2020
Financial relations between leaders of US medical societies and industryJake Checketts, Matt Vassar
Journal of Personality Assessment|October 18, 2008
A reliability generalization study of coefficient alpha for the UCLA loneliness scaleMatt Vassar, James W Crosby
Journal of Educational Evaluation for Health Professions|August 14, 2015
An assessment blueprint for the Advanced Medical Life Support two-day prehospital emergency medical services training program in the United StatesLes R Becker, Matt Vassar
JAMA Dermatology|February 9, 2018
Evaluating Industry Payments Among Dermatology Clinical Practice Guideline Authors-ReplyJake Xavier Checketts, Matt Vassar
BMJ Evidence-Based Medicine|July 26, 2018
Transparency of industry payments needed in clinical practice guidelinesMatt Vassar, Michael Bibens, Cole Wayant
BMJ Evidence-Based Medicine|November 17, 2019
On reporting and interpreting statistical significance and p values in medical researchHerman Aguinis, Matt Vassar, Cole Wayant
Critical Reviews in Oncology/Hematology|March 16, 2020
Methodological quality of oncology noninferiority clinical trialsCole Wayant, Andrew Ross, Matt Vassar
Pageof 42

Showing results (11-20 of 418) with videos related to

Sort By:
Pageof 42
Journal of Dermatological Science|June 18, 2016
Cumulative meta-analysis by precision as a method to evaluate publication biasPaul Atakpo, Matt Vassar
Clinical Obesity|September 6, 2017
Response to: stated conclusion about industry funding is opposite to what the paper's data show: letter regarding "Selective outcome reporting in obesity clinical trials: a cross-sectional review"Andrew Ross, Matt Vassar
Journal of Educational Evaluation for Health Professions|June 4, 2011
An overview of ethnography in healthcare and medical education researchLeigh Goodson, Matt Vassar
BMJ (Clinical Research Ed.)|May 29, 2020
Financial relations between leaders of US medical societies and industryJake Checketts, Matt Vassar
Journal of Personality Assessment|October 18, 2008
A reliability generalization study of coefficient alpha for the UCLA loneliness scaleMatt Vassar, James W Crosby
Journal of Educational Evaluation for Health Professions|August 14, 2015
An assessment blueprint for the Advanced Medical Life Support two-day prehospital emergency medical services training program in the United StatesLes R Becker, Matt Vassar
JAMA Dermatology|February 9, 2018
Evaluating Industry Payments Among Dermatology Clinical Practice Guideline Authors-ReplyJake Xavier Checketts, Matt Vassar
BMJ Evidence-Based Medicine|July 26, 2018
Transparency of industry payments needed in clinical practice guidelinesMatt Vassar, Michael Bibens, Cole Wayant
BMJ Evidence-Based Medicine|November 17, 2019
On reporting and interpreting statistical significance and p values in medical researchHerman Aguinis, Matt Vassar, Cole Wayant
Critical Reviews in Oncology/Hematology|March 16, 2020
Methodological quality of oncology noninferiority clinical trialsCole Wayant, Andrew Ross, Matt Vassar
Pageof 42